Welcome to our dedicated page for Bullfrog AI Holdings news (Ticker: BFRG), a resource for investors and traders seeking the latest updates and insights on Bullfrog AI Holdings stock.
Bullfrog AI Holdings, Inc. (NASDAQ: BFRG) is a dynamic clinical-phase biotechnology company that leverages the power of artificial intelligence and machine learning to advance medical research and improve human health. The company's proprietary platform, bfLEAP™, addresses the challenges of scalability and flexibility in data analysis, offering researchers and clinicians a more precise, multi-dimensional understanding of complex biological data.
Bullfrog AI's core business involves utilizing its AI-driven platform to enhance drug development for both internal projects and collaborations with external partners. The company stands at the forefront of AI-driven drug development, using its technology to create and analyze networks of biological, clinical, and real-world data. This innovation spans from early discovery stages to late-stage clinical trials, aiming to streamline data analytics in therapeutic development, thereby reducing failure rates and development costs.
One of the company's recent significant achievements includes a collaboration with the Lieber Institute for Brain Development (LIBD). This partnership successfully stratified brain expression data from over 2,800 brain samples, offering novel insights into psychiatric conditions such as schizophrenia, bipolar disorder, and major depressive disorder. Through advanced graph analytics and causal AI, this collaboration identified potential molecular subtypes, biomarkers, and drug targets for these conditions.
Financially, Bullfrog AI recently conducted a public offering of 1,507,139 shares of common stock, priced at $3.782 per share, raising approximately $5.7 million before underwriting discounts and offering expenses. WallachBeth Capital LLC acted as the sole book-running manager for this offering, which is expected to close on February 5, 2024, subject to customary closing conditions.
For more information:
- Website: bullfrogai.com
- LinkedIn: Bullfrog AI on LinkedIn
- Investor Contact: Dave Gentry, RedChip Companies, Inc., BFRG@redchip.com, 800-733-2447
FAQ
What is the current stock price of Bullfrog AI Holdings (BFRG)?
What is the market cap of Bullfrog AI Holdings (BFRG)?
What does Bullfrog AI Holdings, Inc. do?
What is bfLEAP?
What are Bullfrog AI's recent achievements?
How does Bullfrog AI's technology benefit drug development?
What financial activities has Bullfrog AI recently conducted?
Who managed Bullfrog AI's recent public offering?
How does Bullfrog AI collaborate with other institutions?
What is the focus of Bullfrog AI's collaboration with the Lieber Institute for Brain Development?
Where can I find more information about Bullfrog AI?
Who is the investor contact for Bullfrog AI?
